In this study, we first compared two different antibodies for precise detection of SOX2 in ameloblastomas, then explored the immunohistological staining patterns of SOX2 across the variants of ameloblastoma and verified their concordance to the sequencing results of BRAF. This evidence concerns the gene SOX2 and ameloblastoma.